Review
Sep 2026
Current therapeutic landscape and future treatment perspectives of MASH
S. Gallage, Olivier Govaere, Q. Anstee et al.
· Nature · 1 citation
3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
Open access
Sep 2026
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Abstract Metabolic dysfunction-associated steatohepatitis (MASH) is not solely a disorder of hepatocellular lipid accumulation, but a multicellular disease driven by coordinated metabolic stress, sterile inflammation, fibrogenesis, and niche remodeling. Recent therapeutic progress with the provisional approval of resme...
Han-Yang Liu, Mingyuan Zhang, F. Tacke
· Drug Design, Development and... · 0 citations
Review
Sep 2026
Molecular mechanisms and pathogenesis of MASH
S. Gallage, Olivier Govaere, Q. Anstee et al.
· Nature · 3 citations